Herpes simplex virus (HSV)-susceptible mice inoculated under conditions favouring the preferential activation of T suppressor (Ts) cells acting on the delayed-type hypersensitivity (DTH) response to the virus were protected from lethal herpes encephalitis and from central nervous system (CNS) demyelination (as reflected by ear paralysis), compared to controls given normal priming. Thus, suppressed DTH was not incompatible with recovery from acute infection and may indeed have been beneficial. Protection could be transferred by T cells from donors given a 'DTH-tolerogenic' priming regime. It was unlikely that protection resulted from enhancement of other mechanisms such as cytotoxic T cell activation, antibody or interferon production, since no reduction of virus spread was observed in protected mice. In addition, several aspects of Ts cell activation by intravenous inoculation of avirulent HSV type 1 have been characterized. Suppression was virus dose-dependent and could be transferred to the efferent limb ofa DTH response. Activation of Ts cells for DTH coincided with an enhanced antibody response. It is suggested that protection in this model may be mediated by Ts cells which act to limit DTH-mediated immunopathology in the CNS.
INTRODUCTION
Although many laboratories are currently engaged in the development of protective vaccines against infection by herpes simplex virus (HSV) a number of questions and paradoxes regarding regulation of the immune response to this virus remain unresolved (Allen & Rapp, 1982) . For example, anti-thymocyte serum (ATs) has been shown to increase susceptibility to HSV in some studies (Rager-Zisman & Allison, 1976; Blyth et aL, 1980) but to decrease it in others (Nahmias et al., 1969) . Similarly, athymic nude mice appear more susceptible (Nagafuchi et al., 1979) or less susceptible than normal littermates (Zawatzky et al., 1979) depending on the route used for inoculation. Furthermore, athymic nude mice or cyclophosphamide-treated mice are less prone to HSV-induced demyelination in the central nervous system (CNS) than normal mice (Townsend, 1981; Townsend & Baringer, 1979) . Many of these animal studies clearly suggest that immunopathology may have a role in the diseases caused by HSV, and that successful prophylaxis may not depend simply on boosting antiviral immunity.
Clinical studies suggest that resolution of the many questions surrounding susceptibility to recurrent HSV will require a better understanding of interactions between lymphocyte subpopulations during infection. Seropositive individuals prone to frequent recrudescence show normal T cell proliferation and lymphokine production in response to HSV between outbreaks, yet have very much suppressed reactivity during the onset of lesions, this suppression correlating with a decreased OKT4/OKT8 ratio in peripheral blood lymphocytes (O'Reilly et al., 1977; Sheridan et al., 1982) .
We have investigated the effect of immunoregulatory changes on the pathogenesis of HSV in a murine model, making use of the fact that T suppressor (Ts) cells acting on the delayed-type hypersensitivity (DTH) response can be preferentially activated by intravenous (i.v.) t Present address: Department of Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel. 0000-6405 © 1985 SGM inoculation of HSV (Nash & Gell, 1983; Schrier et al., 1983) . The suppression induced in this manner is HSV-specific, involving Lytl+23 -, I-J + cells and Lytl-23 ÷, 1-J + cells (Nash et al., 1981; Nash & Gell, 1983) .
We report here that the activation of Ts cells for HSV-1 by i.v. inoculation of avirulent virus is associated with protection from lethal infection, confirming our previous observations on lipopolysaccharide-induced HSV-1 Ts cells (Altmann & Blyth, 1984) .
METHODS
Mice. Male or female NIH inbred or Swiss outbred mice of either sex were obtained from breeding colonies maintained in this department.
Virus. HSV-1, strain SC 16 was used for intradermal (i.d.) inoculation which was in the right pinna, as previously described (Hill et al., 1978) . Two apathogenic HSV-I strains were used for i.v. inoculations: PxC6 and CL(101)TK-. Both were kindly supplied by Dr H. Field, University of Cambridge, Cambridge, U.K.
Intravenous inoculation. In studies involving i.v. and i.d. inoculation of virus into the same recipient, the i.v. inoculum was given a few hours prior to the i.d. inoculation. Donors for adoptive transfer received only the i.v. inoculum, which was given in a volume of 200 ktl.
Measurement of DTH responses. Mice were challenged by i.d. inoculation of 5 x 105 erstwhile p.f.u, of heatinactivated HSV-I SC16 into the left pinna. Responses are expressed as the increment in ear thickness at 24 h, measured using a Mitotoyo engineer's micrometer. Measurements of untreated mouse ears fell in the range 20 x 10 -2 to 32 × 10 -2 ram. Challenge of primed mice with 'mock virus' or of.naive mice with killed virus gave background swellings in the range of 20 to 30~.
Adoptive transfer of spleen cell suspensions. At 28 to 56 days after priming, mouse spleens were removed and pooled, and cell suspensions were made in Dulbecco's modified Eagle's medium by teasing apart with fine forceps followed by filtration through a steel gauze. Cells were washed and counted before resuspending in phosphatebuffered saline and injecting i.v. into syngeneic recipients in a volume of 500 ~tl.
Tcell enrichment. Lymphocytes were separated by passage through nylon wool, as previously described (Julius et al., 1973) . Enriched suspensions contained <8~ Ig + cells by immunofluorescence.
Ear paralysis. Mice were observed for ear paralysis by directing a jet of air at the infected ear and noting the presence or absence of reflex movement of the pinna.
Incidence of latent injection. Dorsal root ganglia (the second, third and fourth cervical ganglia from the righthand side) were cultured in growth medium for 4 days at 37 °C before being homogenized and titrated for detection of infectious virus on Vero cell monolayers (Hill et al., 1975 (Hill et al., , 1978 .
Induction of recurrent disease. At day 28 or more after priming (by which time the infected pinna appeared clinically normal) cellophane tape was applied six times to the skin of the previously infected pinna (Hill et al., 1978) . Mice were then observed daily by x 15 magnification for the emergence of herpetic vesicles on the skin of the pinna.
Statistics. Significance of differences between means was evaluated by Student's t-test or a one-tailed X ~ test (Table 4) .
RESULTS

Effect of i.v. inoculation dose on DTH
Mice were primed with an i.v. inoculum of HSV-1 P2C6 and challenged for DTH 28 days later. Each of the i.v. inocula (5 x 102 to 5 × 105 p.f.u.) induced significant suppression of the response induced by i.d. inoculation alone (P < 0.001 in each case), the extent of suppression increasing with the size of the inoculum (Table 1) .
T-enriched spleen cells from i.v. inoculated mice transfer efferent suppression of DTH
Ts ceils activated by i.v. inoculation of HSV-I can transfer suppression to the efferent limb of the DTH response (Nash & Gell, 1983 ) a result which has been confirmed by us (data not shown). In the present experiment, different numbers of T-enriched or unseparated spleen cells from donors which had received i.v. P2C6 56 days previously were transferred to recipients which had been primed 7 days previously; 1 x l0 s unseparated, primed spleen cells conferred significant suppression on recipients (0-01 < P <0-02; Table 2 ). When T-enriched cells were used, 1 x 106 cells conferred highly significant suppression on recipients (P < 0.001). Thus, spleen T cells transferred at this time can mediate both afferent and efferent suppression of DTH. 
Herpes simplex pathogenesis in tolerant mice
Effect of intravenous inoculation dose on delayed-type hypersensitivity* DTH (mean ear thickness Dose of HSV-1 (p.f.u.) increment_+ 1 S.D./mm x 10 -2) None 33.1 + 2.9 5 × 10 2 18"6 + 2"0 5 × 10 3 17'1 _+ 4.3 5 x 10 4 14"6 + 4"9 5 x 10 5 10'4 _+ 2"4 1299 * NIH female mice aged 6 weeks were used. All groups (four mice per group) were primed by i.d. inoculation of 3 x 105 p.f.u. HSV-I SC16 and challenged 28 days later. NS 0.001 < P < 0"01 * All groups (four to six mice per group) received 3 x 105 p.f.u. HSV-1 SC16 i.d. in the right pinna on day 0, immediately after i.v. inoculation. Mice were NIH 6-week-old females.
~" ys, Not significant.
Neutralizing antibody production in i.v. inoculated mice
Mice received the 'DTH-tolerogenic' regime of HSV-1 SC16 in the right pinna along with one of three different i.v. inocula, and were then bled for assay of HSV antibody at various times after infection (Table 3) , Although this regime activated suppression of DTH it can be seen that the kinetics of antibody production were altered, with significant enhancement seen when compared with controls at day 7 after inoculation, and significant suppression of antibody in one group at day 27.
Effect of i.v. priming on pathogenesis of HSV during acute, latent and recurrent disease
Mice were inoculated using the 'DTH-tolerogenic' regime to observe the effect of such inoculation on pathogenesis during various phases of HSV infection (Table 4) . Swiss outbred mice were used since they are more susceptible to lethal encephalitis than the inbred strain. Mice received 2 × 105 to 4 × 105 HSV-I SC16 in the right pinna, with or without the i.v. inoculum. In control groups, 38 to 40~o of those infected survived the acute infection, the rest dying within the first 6 to 10 days following development of various signs of neurological disease. The groups receiving an i.v. inoculum showed considerable protection from lethal encephalitis, survival being in the range of 75 to 100~. Another sign of CNS involvement in this model is the appearance of ear paralysis, which correlates with the appearance of focal demyelinating lesions in the CNS tissue of the seventh cranial nerve root (Hill et al., 1983) . Mice inoculated via both the i.v. and the i.d. routes were less likely than controls to develop ear paralysis during the acute infection. No clear differences in the incidence of HSV-1 latency were seen between groups. After recovery from acute infection mice were observed for recurrent disease following stripping of the infected pinna with cellophane tape. Although differences in the incidence observed were small, mice inoculated with the 'DTH-tolerogenic' regime tended to show a slightly higher incidence of recurrent disease (Table 4) .
Recipients can be protected from &thai encephalitis by adoptive transfer of T cells from 'DTH-tolerant' donors
The mechanism of protection from lethal encephalitis in the above experiment was unclear, and a study was therefore undertaken to see whether protection could be transferred using T cells from i.v. inoculated donors (Fig. 1) . Donors received 5 x 105 p.f.u. HSV-1 P2C6 28 days before removing spleens for T cell enrichment and adoptive transfer. Naive cell donors were age-matched. Recipients were 3-week-old NIH inbred males since older mice of this strain are extremely resistant to lethal infection with HSV-1, T cells (5 x 106 to 5 × 107) from P2C6 -primed donors conferred substantial protection on recipients, whereas 5 x 107 T cells from naive donors did not. While this result is consistent with the idea that protection may be by Ts cells limiting immunopathology in the CNS, it does not exclude a number of other possibilities. It seems unlikely that protection was the result of transferring an enhanced antibody response to recipients since, in another experiment, transfer of 2 x 107 T cells from i.v. primed donors to recipients who were then challenged, did not transfer any significant enhancement in HSV antibody 7 or 24 days later (data not shown). Furthermore, protection is unlikely to have been by activated macrophages since very few macrophages passed through the nylon wool column.
Neural spread of infectious virus in 'DTH-tolerant' mice
It was postulated from the above experiments that protection was immunological in nature and might take one of two possible forms: either protection was associated with some form of effector mechanism enhancement (e.g. cytotoxic T lymphocytes, NK cells, interferon), in which case protection would be the result of decreased virus spread to the CNS, or it was associated with Ts cell activation which limited DTH-mediated immunopathology in the CNS. In this case, protected mice would show the Game spread of infection as controls. To test these two possibilities, 'DTH-tolerant' or control mice were sacrificed at 4 or 5 days after i.d, inoculation 1"6 1.1 2"1 3"7 2"1 1-9 < 0 t "0 2'0 3'6 2"0 < 0 1.2 1.4 1.7 <0 1"9 2"1 3'7 2.7 1"6 <0 1.9 2.1 3"6 2.1 1'8 2"8 1"0 <0 3"7 <0 1.8 1.7 2'9 <0 3'7 3"6 1 "7 5 x 105 HSV-I P,_Co <0 <0 <0 <0 1"6 0 i.v. + 4 x l0 s 3"6 3.6 2.4 <0 3"7 2"2 HSV-1 SC16 i.d. § 2'9 <0 <0 3"4 2"8 3'6 2-6 1'5 0 <3-7 3"5 2"1 <0 <0 <0 l'3 2"0 <0 * Outbred males aged 4 weeks were used. Results represent titres in tissue from individual mice. "J" Including a small piece of brain stem (approx. 3 mm3). C2, C3, C~, Cervical ganglia 2, 3 and 4. § Based on reproducible observations of DTH following challenge of mice primed in this manner (e.g. Tables 1, 2), this group can be considered tolerant with respect to DTH to HSV-I. and various parts of the peripheral nervous system (PNS) or CNS were tested for the spread of HSV-1 (Table 5 ). There was no evidence of decreased virus spread to the CNS in 'DTH-tolerant' mice, but virus reached the cervical ganglia later in 'DTH-tolerant' mice than in controls. Thus, protection does not appear to depend on limiting the spread of virus to the CNS.
DISCUSSION
Immunologists have long studied cellular interactions in the regulation of DTH to heterologous erythrocytes, haptenated spleen cells or contact sensitizing agents, one of the underlying assumptions being that the effector/suppressor cell interactions observed reflect the result of evolutionary pressure to develop potent T cell immunity to viral infections without excessive immunopathology. However, the application of this knowledge to experimental models of viral infection has been relatively recent (Liew et al., 1979; Nash et al., 1981 ; Schrier et al., 1983) .
The findings in this paper together with those of previous workers investigating the generation of Ts cells controlling responses to HSV-1 suggest that activation of these cells by viral antigen may involve very different mechanisms from those leading to activation of DTH effector cells (TDH). The strains of virus which were used here for stimulating Ts cells replicate poorly in host cells and are very poor stimulators of TD., even when inoculated i.d. (D. M. Altmann, unpublished observations). Furthermore, these HSV-l-specific Ts cells are apparently able to recognize viral antigen in the absence of self-major histocompatibility complex molecules, since they can be substantially enriched by panning on HSV-l-infected Vero cell monolayers (D. M. Altmann, unpublished observations).
The finding of previous workers that 'DTH-tolerogenic' inoculation with HSV-1 stimulates an enhanced antibody response has been confirmed here, although it is unclear whether there is any causal relationship between the two events (Schrier et al., 1983) . However, a transfer of HSV antibody from i.v. inoculated mice cannot suppress a DTH response in recipients (Nash et al., 1981) .
We have shown that the pathogenesis of HSV infection can be affected quite profoundly by inoculation regimes which favour the stimulation of different T cell subpopulations. For example, mice primed under conditions favouring the activation of Ts cells (and an enhanced antibody response) suffer less CNS demyelination as reflected by ear paralysis than controls. The idea that this protection may be mediated by beneficial Ts cells rather than by CTL or antibody-mediated restriction of HSV ingress into the CNS is supported by our finding that protected mice showed no less spread of virus to the CNS than controls. Furthermore, the activation of HSV-specific Ts cells by simultaneous injection of lipopolysaccharide and HSV (which does not involve an enhancement of HSV antibody) also results in a decreased incidence of ear paralysis, as does treatment with cyclosporin A (Altmann & Blyth, 1984; and unpublished observations) . While we cannot entirely exclude the possibility of protection by cytotoxic lymphocytes, natural killer cells or other mechanisms, it is hard to see how they might act except by restricting the spread of virus. This question may not be entirely resolved unless highly purified or cloned Ts populations can be used for transfer experiments. There is a precedent for protective Ts cells in viral infection since Ts cell transfer can reverse the lethal effect Of TDH cells which can otherwise cause asphyxia through lung consolidation in the influenza model of Liew & Russell (1983) .
Our results suggest that although DTH may have an important role in the clearance of virus from the skin (Nash & Ashford, 1982) , the consequences O f this response in the CNS may be extremely damaging. Such damage may result from a simple by-stander effect resulting from the DTH response to infected glial cells, may involve cross-reactivity between components on infected and uninfected cells, or may involve the generation of autoreactive clones to host cell components such as myelin basic protein as previously shown in virus-induced demyelination (Watanabe et al., 1983) .
While Ts cell activation may protect from lethal encephalitis, there is a suggestion that protected mice are susceptible to a higher incidence of recurrent disease after cellophane tape stripping than controls. This effect cannot be explained by protection from death selecting in favour of latently infected mice, since the incidence of latency was not greatly different between P2Co-inoculated mice and controls. The slightly enhanced incidence of recrudescence in mice inoculated with the 'DTH tolerogenic' regime would be compatible with the idea that the DTH response is important for the clearance of HSV-1 from the skin (Nash & Ashford, 1982) .
Thus, the preferential activation of Ts cells acting on the DTH response to HSV-1 may be useful in limiting immunopathology in the CNS, but allows increased viral pathology in the skin.
